Cervical Erector Spinae Block for Shoulder Surgery
Evaluating the Effectiveness of Cervical Erector Spinae Block for Shoulder Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
Arthroscopic shoulder surgery is often associated with moderate to severe postoperative pain that may interfere with patients' early mobilization, recovery and quality of life. In addition, by using an effective analgesic technique, a patient may experience less nausea, vomiting and drowsiness after surgery that are associated with the use of opioids to manage postoperative pain. Erector spinae plane block (ESPB) has been used in many different indications for acute pain treatment at different thoracic and lumbar levels. Recently, staining the roots of the brachial plexus has been reported in a cadaveric study of the cervical ESPB (1). However, there are only few case reports related to efficiency and safety of this newly defined cervical ESPB technique (2) . The primary objective of this randomized controlled is investigate the post-operative analgesic effectiveness of ultrasound guided single-shot cervical ESPB for patients undergoing arthroscopic shoulder surgery in comparison to those receiving conventional parentheral opioid analgesia alone. Secondary objective is testing the safety of this newly defined block in terms of incidence of complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Jun 2020
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2020
CompletedFirst Posted
Study publicly available on registry
May 21, 2020
CompletedStudy Start
First participant enrolled
June 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2020
CompletedMay 22, 2020
May 1, 2020
4 months
May 15, 2020
May 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphine consumption
All patients will be provided with IV morphine PCA and morphine consumption after 24 hour postoperatively will be recorded.
24 hour postoperatively
Secondary Outcomes (2)
Numering Rating Scale scores for pain
24 hour
Postoperative nausea and vomiting
24 hour
Study Arms (2)
Block group
ACTIVE COMPARATORCervical Erector Spinae Plane Block administered group
Control group
SHAM COMPARATORControl group
Interventions
Cervical erector spinae plane block will be administered before the surgery
24 hour morphine consumption will be recorded
Eligibility Criteria
You may qualify if:
- years of agge
- ASA I-II
- Undergoing elective shoulder surgery
You may not qualify if:
- infection of the skin at the site of needle puncture area
- patients with known allergies to any of the study drugs
- coagulopathy
- recent use of analgesic drugs
- obesity (body mass index \>35 kg/m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Konya Necmettin Erbakan Üniversitesilead
- Ataturk Universitycollaborator
Study Sites (1)
Necmettin Erbakan University
Konya, Turkey (Türkiye)
Related Publications (2)
Hamadnalla H, Elsharkawy H, Shimada T, Maheshwari K, Esa WAS, Tsui BCH. Cervical erector spinae plane block catheter for shoulder disarticulation surgery. Can J Anaesth. 2019 Sep;66(9):1129-1131. doi: 10.1007/s12630-019-01421-9. Epub 2019 Jun 3. No abstract available.
PMID: 31161549BACKGROUNDElsharkawy H, Ince I, Hamadnalla H, Drake RL, Tsui BCH. Cervical erector spinae plane block: a cadaver study. Reg Anesth Pain Med. 2020 Jul;45(7):552-556. doi: 10.1136/rapm-2019-101154. Epub 2020 Apr 21.
PMID: 32321860RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alper Kilicaslan, MD, Assoc.Prof
Necmettin Erbakan University Meram Medical Faculty
- PRINCIPAL INVESTIGATOR
İlker İnce, MD, Assoc.Prof
Ataturk University Medical Faculty
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Assoc.Professor
Study Record Dates
First Submitted
May 15, 2020
First Posted
May 21, 2020
Study Start
June 15, 2020
Primary Completion
September 30, 2020
Study Completion
October 15, 2020
Last Updated
May 22, 2020
Record last verified: 2020-05